» Articles » PMID: 26530516

Meta-analysis of Laparoscopic Surgery for Recurrent Crohn's Disease

Overview
Journal Surg Today
Specialty General Surgery
Date 2015 Nov 5
PMID 26530516
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purposes: It remains unclear whether laparoscopic surgery is suitable for recurrent Crohn's disease (CD). The objective of this meta-analysis was to evaluate the safety and feasibility of laparoscopic resection for recurrent vs. primary CD by comparing intraoperative and postoperative outcomes.

Methods: We searched the PubMed and Cochrane Library databases for studies that compared complications associated with laparoscopic resection for primary and recurrent CD. The primary study endpoints were conversion rates and postoperative complication rates.

Results: Seven trials with a collective total of 627 participants (413 with primary CD and 214 with recurrent CD) met our inclusion criteria. Laparoscopic resection was associated with a significantly higher conversion rate when performed for recurrent CD than for primary CD (OR = 2.53; 95 % CI 1.22-5.25; p = 0.01). However, there was no significant difference in the total complication rate between laparoscopic resection for primary vs. that for recurrent CD (OR = 1.41; 95 % CI 0.86-2.34; p = 0.18).

Conclusions: Although a higher conversion rate suggests technical complexity, laparoscopic resection for recurrent CD is considered a safe and feasible procedure, without an increased risk of postoperative complications.

Citing Articles

Outcomes of surgical treatment for enterovesical fistula in Crohn's disease.

Hattori N, Nakayama G, Umeda S, Nakamura M, Yamamura T, Sawada T Nagoya J Med Sci. 2024; 86(2):280-291.

PMID: 38962416 PMC: 11219233. DOI: 10.18999/nagjms.86.2.280.


Minimally invasive surgery in Crohn's disease: state-of-the-art review.

Liu W, Zhou W Front Surg. 2023; 10:1216014.

PMID: 37529660 PMC: 10388240. DOI: 10.3389/fsurg.2023.1216014.


Open approach for ileocolic resection in Crohn's disease in the era of minimally invasive surgery: indications and perioperative outcomes in a referral center.

Calini G, Abdalla S, Abd El Aziz M, Benammi S, Merchea A, Behm K Updates Surg. 2023; 75(5):1179-1185.

PMID: 37149508 DOI: 10.1007/s13304-023-01528-1.


Risk factors and predictors of 30-day complications and conversion to open surgery after repeat ileocolic resection of Crohn's disease.

Emile S, Freund M, Horesh N, Garoufalia Z, Gefen R, Silva-Alvarenga E Surg Endosc. 2022; 37(2):941-949.

PMID: 36068385 DOI: 10.1007/s00464-022-09557-4.


Surgical Strategies to Reduce Postoperative Recurrence of Crohn's Disease After Ileocolic Resection.

Reynolds I, Doogan K, Ryan E, Hechtl D, Lecot F, Arya S Front Surg. 2022; 8:804137.

PMID: 34977147 PMC: 8718441. DOI: 10.3389/fsurg.2021.804137.


References
1.
Okabayashi K, Hasegawa H, Watanabe M, Nishibori H, Ishii Y, Hibi T . Indications for laparoscopic surgery for Crohn's disease using the Vienna Classification. Colorectal Dis. 2007; 9(9):825-9. DOI: 10.1111/j.1463-1318.2007.01294.x. View

2.
Borenstein M, Hedges L, Higgins J, Rothstein H . A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2015; 1(2):97-111. DOI: 10.1002/jrsm.12. View

3.
Polle S, Wind J, Ubbink D, Hommes D, Gouma D, Bemelman W . Short-term outcomes after laparoscopic ileocolic resection for Crohn's disease. A systematic review. Dig Surg. 2006; 23(5-6):346-57. DOI: 10.1159/000097950. View

4.
Hansen R, Gartlehner G, Powell G, Sandler R . Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol. 2007; 5(6):729-35. DOI: 10.1016/j.cgh.2007.02.016. View

5.
Motson R, Kadirkamanathan S, Gallegos N . Minimally invasive surgery for ileo-colic Crohn's disease. Colorectal Dis. 2003; 4(2):127-131. DOI: 10.1046/j.1463-1318.2002.00297.x. View